Residency scramble: program directors' experiences with the Pharmacy Online Residency Centralized Application Service

J Russell May1, Juliana Chan, Patrick D Fuller

  • 1J. Russell May, Pharm.D., FASHP, is Clinical Professor, University of Georgia College of Pharmacy, Augusta, and Clinical Pharmacy Specialist, Georgia Regents Medical Center, Augusta. Juliana Chan, Pharm.D., FCCP, BCACP, is Clinical Associate Professor, University of Illinois College of Pharmacy, Chicago, and Clinical Pharmacist, University of Illinois Hospital and Health Sciences System, Chicago. Patrick D. Fuller, B.S., Pharm.D., BCPS, is Pharmacy Staff Development Specialist and Postgraduate Year 1 Residency Program Director, Nebraska Medical Center, Omaha. Karalea Jasiak, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Emergency Department, Wishard Health Services, Indianapolis, IN. Marcie Lepkowsky, Pharm.D., is Director, Postgraduate Year 1 Acute Care Residency Program, Department of Pharmacy, University of California San Diego Health System, San Diego. Holly Phillips, Pharm.D., is Acute Care Pharmacist Manager and Postgraduate Year 1 Residency Program Director, University of Colorado Hospital, Aurora.

Summary

Residency program directors found the Pharmacy Online Residency Centralized Application Service (PhORCAS) improved the scramble process. Guidelines and PhORCAS facilitated filling unmatched positions, though concerns about the process

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
Healthcare Agencies II01:17

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
958
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
398